Anthrax as a Bioweapon
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What do sheep, Islamic fascists and Vladimir Putin have in common? Anthrax. The "poor man’s" weapon of mass destruction, this disease has been recognized since Biblical times. Join our guest, Dr. Nicholas Bergman has his discusses the development of anthrax into a weapon of mass destruction. Dr. Bergman received his PhD in biochemistry and molecular biology at the Massachusetts Institute of Technology. He is currently an Assistant Professor in the School of Biology at the Georgia Institute of Technology in Atlanta. He has published a paper examining some of the genomic properties of Anthrax in the Journal of Bacteriology.
Overview
What do sheep, Islamic fascists and Vladimir Putin have in common? Anthrax. The "poor man’s" weapon of mass destruction, this disease has been recognized since Biblical times. Join our guest, Dr. Nicholas Bergman has his discusses the development of anthrax into a weapon of mass destruction. Dr. Bergman received his PhD in biochemistry and molecular biology at the Massachusetts Institute of Technology. He is currently an Assistant Professor in the School of Biology at the Georgia Institute of Technology in Atlanta. He has published a paper examining some of the genomic properties of Anthrax in the Journal of Bacteriology.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?